Goldman Sachs Lowers Price Target for Novo Nordisk to 353 Danish Kroner, Reiterates Buy
26/11 10:11
Goldman Sachs has reduced its price target for Novo Nordisk to 353 Danish kroner from the previous 391, while maintaining its buy recommendation, according to Bloomberg News (BN)....